CD8A and melanoma: Here, we confirmed that CD14+HLA-DRlow cells, isolated from peripheral blood mononuclear cells obtained from melanoma patients, have the ability to suppress the proliferation of autologous CD8+ T cells in a dose-dependent manner (Figure 6A).